Full Breakdown
Trump Administration Moves to Ban Gender-Affirming Care for Minors
12/18/2025, 11:42:58 PM
Overview of Proposed Regulations
On December 18, 2025, the Trump administration announced a series of proposed regulations aimed at effectively banning gender-affirming care for minors across the United States. Health Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services (CMS), revealed that hospitals providing such care would risk losing federal Medicare and Medicaid funding. This move follows a broader trend of legislative and executive actions targeting transgender rights and healthcare.
Key Components of the Proposal
The proposed regulations include two primary measures:
1. Funding Restrictions: Hospitals that provide gender-affirming treatments, including puberty blockers, hormone therapy, and surgeries for individuals under 18, would be barred from participating in Medicare and Medicaid programs. This would significantly impact nearly all hospitals in the U.S., as they rely heavily on these federal funding sources.
2. Medicaid and CHIP Funding: The regulations would also prohibit Medicaid and the Children’s Health Insurance Program (CHIP) from covering gender-affirming care for minors under 19.
These proposals are set to enter a 60-day public comment period before any final decisions are made.
Official Statements and Responses
During the announcement, Kennedy stated, “So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people. This is not medicine; it is malpractice.” He emphasized that the administration aims to protect children from what he described as "unsafe, irreversible practices." Dr. Oz echoed these sentiments, asserting that the proposed rules are intended to prevent children from being subjected to experimental interventions.
In contrast, numerous medical organizations, including the American Academy of Pediatrics and the American Medical Association, have criticized these measures. They argue that gender-affirming care is essential for the mental health and well-being of transgender youth. Susan Kressly, president of the American Academy of Pediatrics, stated that the proposed rules misrepresent medical consensus and could harm families in need.
Criticism and Opposition
The announcement has drawn widespread condemnation from LGBTQ+ advocacy groups, healthcare providers, and families of transgender youth. The American Civil Liberties Union (ACLU) has pledged to challenge the regulations in court, labeling them as unconstitutional attacks on the rights of transgender youth and their families. Letitia James, the Attorney General of New York, described the proposals as "reprehensible," asserting that they would isolate and harm adolescents.
Families affected by these changes have expressed deep concern. One mother of a transgender teen remarked, “If we can't stop the government from legislating what health care families can receive in consultation with their doctors, then I don't recognize this America.”
Broader Implications
The proposed regulations come amid a growing trend of state-level bans on gender-affirming care, with 27 states already implementing restrictions. The federal measures could further exacerbate the healthcare landscape for transgender youth, potentially leading to a patchwork of access across the country. Critics warn that these actions could increase mental health risks among affected youth, including heightened anxiety and depression.
What's Next?
The proposed rules will undergo a public comment period, allowing stakeholders to voice their opinions before any final decisions are made. Legal challenges are anticipated, as advocacy groups and state officials prepare to contest the regulations in court. The outcome of this regulatory process could significantly influence the future of transgender healthcare in the United States.
